New Haven, CT

Launching in Fall 2021, the program has quickly amassed support from premier institutions, investors, entrepreneurs, and scientists in the region.

REGIONAL LEADERSHIP

2023 COHORT

Nucleate's Activator forms pioneering biotech companies without taking equity.
Timeline and FAQ.

01

Approval from PI
02

Well defined technology / product backed by preliminary scientific research (Therapeutic modalities - Platform technologies - Diagnostics - Medical Devices)
03

Existing IP to protect the technology, or clear path to file IP within the next year
04

Clear potential to apply the technology
05

Team intending and willing to 'spin-out' in the near future